Effectiveness of a Person-centred Prescription Model at the End of Life

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 15, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2021

Conditions
End-Of-LifeInappropriate PrescribingDeprescriptionsPalliative MedicineGeriatrics
Interventions
OTHER

Person-Centred Prescription Model

"Step 1: Identify patients with advanced chronic condition and limited life expectancy.~Step 2: Interview with patients or closes caregiver.~Step 3: Medication Review~The clinical pharmacist conduct a structured medication review based on the medication appropriateness index (MAI):~* Indication/effectiveness: Product information, STOPPFrail (Screening Tool of Older Persons' Prescriptions in Frail adults with limited life expectancy) criteria and Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.~* Dosage adjustment: Product Information and Lexi-Comp's Geriatric Dosage Handbook.~* Correct and practical directions: Medication Regimen Complexity Index (MRCI).~* Drug-drug interactions: Bot Plus/Beers Criteria and drug burden index (DBI), which measures dose-dependent anticholinergic and sedative loads.~* Drug-disease interactions: Beers Criteria.~* Duplication, duration and cost-effectiveness: Product information.~Step 4: Treatment Plan"

Trial Locations (1)

20018

Matia Foundation, Donostia / San Sebastian

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of the Basque Country (UPV/EHU)

OTHER

collaborator

Universidad de León

OTHER

lead

Matia Foundation

OTHER

NCT05454644 - Effectiveness of a Person-centred Prescription Model at the End of Life | Biotech Hunter | Biotech Hunter